The Viral Hemorrhagic Fever Consortium
At a Glance
- Status: Active Consortium
- Year Launched: 2010
- Initiating Organization: NIH
- Initiator Type: Government
- Rare disease
- Disease focus:
Viral Hemorrhagic Fever, Lassa Fever, Ebola
- Location: International
The Viral Hemorrhagic Fever Consortium was established in 2010 as a result of a five-year $15 million contract awarded to Tulane University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). This contract was awarded for Tulane's ongoing efforts to treat and prevent Lassa Fever, a disease that threatens hundreds of thousands of lives annually in West Africa and is classified as a potential bioterrorism threat.
The goal of the Consortium is to understand mechanisms related to the human immune response to Lassa virus infection. Specifically, by understanding what parts of the virus are recognized by the immune system, we can better understand mechanisms of antibody-mediated protection or pathogenesis in humans with Lassa Fever.
Since the consortiums beginning it has grown to encompassing more than just research to better understand the Lassa Virus. The consortium works to discover ways to treat and prevent Lassa Virus and expanded its scope to include Ebola, Marburg, and other Arenaviruses that are of great concern to public health and bioterrorism.
Structure & Governance
The consortium is overseen by Tulane University
The consortium was awarded a 5-year, $15 million grant by the National Institute of Allergy and Infectious Disease, which is part of the NIH.
During the Human Evolution Project, the consortium engaged patients to study genome biomarkers that would be useful in understanding the Lassa Virus.
For news relating to the consortium, click here
Points of Contact
Dr. Robert Garry
Department of Microbiology & Immunology
Tulane University Health Sciences Center
1430 Tulane Avenue, SL-38
New Orleans, LA, 70112
Phone: (504) 988-2027
Sponsors & Partners
Scripps Research Institute
University of California at San Diego
University of Texas Medical Branch
Autoimmune Technologies LLC
Corgenix Medical Corporation
Kenema Government Hospital (Sierra Leone)
Irruna Specialist Teaching Hospital (Nigeria)